Shari M. Kaiser

4.1k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

Shari M. Kaiser is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Shari M. Kaiser has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Hematology and 11 papers in Immunology. Recurrent topics in Shari M. Kaiser's work include CAR-T cell therapy research (15 papers), Multiple Myeloma Research and Treatments (12 papers) and interferon and immune responses (4 papers). Shari M. Kaiser is often cited by papers focused on CAR-T cell therapy research (15 papers), Multiple Myeloma Research and Treatments (12 papers) and interferon and immune responses (4 papers). Shari M. Kaiser collaborates with scholars based in United States, Germany and Spain. Shari M. Kaiser's co-authors include Michael Emerman, Harmit S. Malik, Jie Zang, Barbara Sato, Nanette H. Bishopric, Daryl J. Discher, Olga M. Hernandez, Keith A. Webster, Garry P. Nolan and Michael A. Curran and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Shari M. Kaiser

26 papers receiving 1.0k citations

Hit Papers

Biallelic loss of BCMA as a resistance mechanism to CAR T... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
    2021 236 citations Mehmet Samur, Mariateresa Fulciniti et al. Nature Communications profile →

Peers

Shari M. Kaiser
Karen Duus United States
Mani Larijani Canada
Haixin Yu China
Philippe Leissner France
F. Roubinet France
Zhicheng Zhou United States
Anna Skaletskaya United States
Yuya Nagai Japan
Peter Smith United States
Sunil S. Metkar United States
Karen Duus United States
Shari M. Kaiser
Citations per year, relative to Shari M. Kaiser Shari M. Kaiser (= 1×) peers Karen Duus

Countries citing papers authored by Shari M. Kaiser

Since Specialization
Citations

This map shows the geographic impact of Shari M. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari M. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari M. Kaiser more than expected).

Fields of papers citing papers by Shari M. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shari M. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari M. Kaiser. The network helps show where Shari M. Kaiser may publish in the future.

Co-authorship network of co-authors of Shari M. Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Shari M. Kaiser. A scholar is included among the top collaborators of Shari M. Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shari M. Kaiser. Shari M. Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Nathan, Ethan Thompson, Nicholas Stong, et al.. (2025). Distinct patient, tumour and chimeric antigen receptor T‐cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma. British Journal of Haematology. 207(3). 1019–1028. 1 indexed citations
2.
Paiva, Bruno, Irene Manrique, Ethan Thompson, et al.. (2024). Biological and Clinical Significance of Endogenous and Chimeric Antigen Receptor (CAR) T Cell Immune Profiling in Relapsed/Refractory Multiple Myeloma (RRMM) Patients. Blood. 144(Supplement 1). 900–900. 1 indexed citations
3.
4.
5.
Paiva, Bruno, Irene Manrique, Julie Rytlewski, et al.. (2023). Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel. Blood Cancer Discovery. 4(5). 365–373. 11 indexed citations
6.
Stong, Nicholas, Ethan Thompson, Amy Xu, et al.. (2023). Tumor-intrinsic features associated with progression-free survival (PFS) in patients (pts) with relapsed and refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel).. Journal of Clinical Oncology. 41(16_suppl). 8035–8035. 1 indexed citations
7.
Waldschmidt, Johannes M., Sankalp Arora, Tushara Vijaykumar, et al.. (2022). Nivolumab-Based Salvage Therapy to Restore T Cell Fitness in Penta-Refractory Multiple Myeloma with Relapse to Anti-BCMA CAR T Cell Therapy. Blood. 140(Supplement 1). 9925–9926. 1 indexed citations
8.
Samur, Mehmet, Mariateresa Fulciniti, Anıl Aktaş Samur, et al.. (2021). Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma. Nature Communications. 12(1). 868–868. 236 indexed citations breakdown →
9.
Samur, Mehmet, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, et al.. (2020). Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma. Blood. 136(Supplement 1). 14–14. 10 indexed citations
10.
Rytlewski, Julie, Deepu Madduri, Timothy Campbell, et al.. (2020). Effects of Prior Alkylating Therapies on Preinfusion Patient Characteristics and Starting Material for CAR T Cell Product Manufacturing in Late-Line Multiple Myeloma. Blood. 136(Supplement 1). 7–8. 9 indexed citations
11.
Thompson, Ethan, Yue Jiang, Timothy Campbell, et al.. (2019). Markers of Initial and Long-Term Responses to Idecabtagene Vicleucel (Ide-Cel; bb2121) in the CRB-401 Study in Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 4328–4328. 3 indexed citations
12.
Loo, Yueh–Ming, Courtney Wilkins, Sowmya Pattabhi, et al.. (2016). RIG-ging the host innate immune response for vaccine adjuvant and antiviral therapy. The Journal of Immunology. 196(1_Supplement). 76.3–76.3. 1 indexed citations
13.
Pattabhi, Sowmya, Courtney Wilkins, Ran Dong, et al.. (2015). Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway. Journal of Virology. 90(5). 2372–2387. 56 indexed citations
14.
Rosenberger, Carrie M., Rebecca Podyminogin, Peter S. Askovich, et al.. (2013). Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model. Journal of General Virology. 95(2). 350–362. 37 indexed citations
15.
Aderem, Alan, Joshua Adkins, Charles Ansong, et al.. (2011). A Systems Biology Approach to Infectious Disease Research: Innovating the Pathogen-Host Research Paradigm. mBio. 2(1). e00325–10. 91 indexed citations
16.
Diehl, William E., et al.. (2008). Identification of Postentry Restrictions to Mason-Pfizer Monkey Virus Infection in New World Monkey Cells. Journal of Virology. 82(22). 11140–11151. 27 indexed citations
17.
18.
Spiegel, Paul, Shari M. Kaiser, Julian A. Simon, & Barry Stoddard. (2004). Disruption of Protein-Membrane Binding and Identification of Small-Molecule Inhibitors of Coagulation Factor VIII. Chemistry & Biology. 11(10). 1413–1422. 28 indexed citations
19.
Curran, Michael A., et al.. (2000). Efficient Transduction of Nondividing Cells by Optimized Feline Immunodeficiency Virus Vectors. Molecular Therapy. 1(1). 31–38. 92 indexed citations
20.
Bishopric, Nanette H., Daryl J. Discher, Shari M. Kaiser, et al.. (1999). Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. Journal of Clinical Investigation. 104(3). 239–252. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Duus Breakdown of academic impact, for papers by Mani Larijani Breakdown of academic impact, for papers by Haixin Yu Breakdown of academic impact, for papers by Philippe Leissner Breakdown of academic impact, for papers by F. Roubinet Breakdown of academic impact, for papers by Zhicheng Zhou Breakdown of academic impact, for papers by Anna Skaletskaya Breakdown of academic impact, for papers by Yuya Nagai Breakdown of academic impact, for papers by Peter Smith Breakdown of academic impact, for papers by Sunil S. Metkar
Rankless by CCL
2026